Foundation for Angelman Syndrome Therapeutics

Analysis

Foundation for Angelman Syndrome Therapeutics is a registered charity in United States, based in Austin, TX. It received its IRS tax-exemption ruling in December 2008, 18 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Foundation for Angelman Syndrome Therapeutics reported income of $6.5m and spending of $23.2m, spending 356% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income grew from $5.7m to $6.5m (+14%), an average of +3.3% a year. The sharpest change came in the year to December 2022, when income rose by 1219%. Over the whole period it spent 58% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Foundation for Angelman Syndrome Therapeutics sits at the 81st percentile: it is larger than about 81% of them. Against every charity in United States with reported income it ranks in the 93rd percentile, and in the 95th percentile within TX. Charities of a similar size with the same main cause include Cdac Behavioral Healthcare Inc ($6.5m), Ohio Eastern Star Health Care Center Inc ($6.5m) and Hackensack Meridian Team Health PC ($6.5m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 59% of the total. Compensation of current officers, directors and key employees was $593k (2.6% of expenses). Other salaries and wages came to $782k. At year end it held assets of $58.4m against liabilities of $18.6m, net assets of $39.8m. It reported 9 employees.